“…Subsets of CD-1 mice who had been treated with NWD in-utero subsequently received in their drinking water an anti-inflammatory strain of Lactobacillus reuteri ATCC-PTA-6475 cultivated as described elsewhere (8,9), with live organisms supplied at a starting dosage of 3.5×10 5 organisms/mouse/day in drinking water (4). Live bacterial counts in water bottles were calculated to be 1.4×10 6 colony forming units (CFU) per mouse on day 1, 4.1×10 5 CFU on day 2, and 1.1×10 5 CFU on day 3, and L reuteri was detectable by PCR in feces and bowel of mice undergoing the dosing regimen, as described in detail in Lakritz et al (2014) (4). Control mice received regular drinking water.…”